Modern Care Journal

Published by: Kowsar

Alterationsinserum Antitrypsin Level and Its Association with Pulmonary Complications Among Patients with Lung Tuberculosis

Reza Eslami Manoochehri 1 , Sayyed Gholamreza Mortazavimoghaddam 2 , * , Mohammad Hasan Namaei 3 and Mahmod Zardast 4
Authors Information
1 Department of Internal Medicine, Vali-e-Asre Hospital, School of Medicine, Birjand University of Medical Sciences, Birjand, IR Iran
2 Pulmonary Division, Department of Internal Medicine, Vali-e-Asre Hospital, School of Medicine, Birjand University of Medical Sciences, Birjand, IR Iran
3 Department of Microbiology, School of Medicine, Birjand University of Medical Sciences, Birjand, IR Iran
4 Department of Pathology, Vali-e-Asre Hospital, School of Medicine, Birjand University of Medical Sciences, Birjand, IR Iran
Article information
  • Modern Care Journal: April 2017, 14 (2); e64569
  • Published Online: April 30, 2017
  • Article Type: Research Article
  • Received: January 29, 2017
  • Accepted: March 4, 2017
  • DOI: 10.5812/modernc.64569

To Cite: Eslami Manoochehri R, Mortazavimoghaddam S G, Namaei M H, Zardast M. Alterationsinserum Antitrypsin Level and Its Association with Pulmonary Complications Among Patients with Lung Tuberculosis, Mod Care J. 2017 ;14(2):e64569. doi: 10.5812/modernc.64569.

Abstract
Copyright © 2017, Modern Care Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
References
  • 1. Chakaya J, Kirenga B, Getahun H. Long term complications after completion of pulmonary tuberculosis treatment: A quest for a public health approach. J Clin Tuberculosis Other Mycobacterial Dis. 2016;3:10-2. doi: 10.1016/j.jctube.2016.03.001.
  • 2. Hassan IS, Al-Jahdali HH. Obstructive airways disease in patients with significant post- tuberculous lung scarring. Saudi Med J. 2005;26(7):1155-7. [PubMed: 16047080].
  • 3. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, Gold Scientific Committee . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256-76. doi: 10.1164/ajrccm.163.5.2101039. [PubMed: 11316667].
  • 4. Chakrabarti B, Calverley PM, Davies PD. Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2007;2(3):263-72. [PubMed: 18229564].
  • 5. Yakar HI, Gunen H, Pehlivan E, Aydogan S. The role of tuberculosis in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:323-9. doi: 10.2147/COPD.S116086. [PubMed: 28176901].
  • 6. Caballero A, Torres-Duque CA, Jaramillo C, Bolivar F, Sanabria F, Osorio P, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. 2008;133(2):343-9. doi: 10.1378/chest.07-1361. [PubMed: 17951621].
  • 7. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(4):258-66. discussion 290-1. doi: 10.1513/pats.200504-045SR. [PubMed: 16267346].
  • 8. Welle I, Bakke PS, Eide GE, Fagerhol MK, Omenaas E, Gulsvik A. Increased circulating levels of alpha1-antitrypsin and calprotectin are associated with reduced gas diffusion in the lungs. Eur Respir J. 2001;17(6):1105-11. [PubMed: 11491151].
  • 9. McCarthy C, Saldova R, Wormald MR, Rudd PM, McElvaney NG, Reeves EP. The role and importance of glycosylation of acute phase proteins with focus on alpha-1 antitrypsin in acute and chronic inflammatory conditions. J Proteome Res. 2014;13(7):3131-43. doi: 10.1021/pr500146y. [PubMed: 24892502].
  • 10. Lomas DA. Does Protease-Antiprotease Imbalance Explain Chronic Obstructive Pulmonary Disease?. Ann Am Thorac Soc. 2016;13 Suppl 2:S130-7. doi: 10.1513/AnnalsATS.201504-196KV. [PubMed: 27115947].
  • 11. Ong CW, Elkington PT, Friedland JS. Tuberculosis, pulmonary cavitation, and matrix metalloproteinases. Am J Respir Crit Care Med. 2014;190(1):9-18. doi: 10.1164/rccm.201311-2106PP. [PubMed: 24713029].
  • 12. Navratilova Z, Kolek V, Petrek M. Matrix Metalloproteinases and Their Inhibitors in Chronic Obstructive Pulmonary Disease. Arch Immunol Ther Exp (Warsz). 2016;64(3):177-93. doi: 10.1007/s00005-015-0375-5. [PubMed: 26611761].
  • 13. Khara NV, Patel BM, Kshatriya RM, Patel SN, Paliwal RP. Post TB Pulmonary Disability: An Ongoing Challenge for India. Nat J Med Res. 2016;6(3):247-50.
  • 14. Grange JM, Kardjito T, Setiabudi I. A study of acute-phase reactant proteins in Indonesian patients with pulmonary tuberculosis. Tubercle. 1984;65(1):23-39. [PubMed: 6428016].
  • 15. Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, Kohnlein T, Welte T. The discovery of alpha1-antitrypsin and its role in health and disease. Respir Med. 2011;105(8):1129-39. doi: 10.1016/j.rmed.2011.02.002. [PubMed: 21367592].
  • 16. Matalon S, Elad H, Brazowski E, Santo E, Tulchinsky H, Dotan I. Serum alpha-1 antitrypsin: a noninvasive marker of pouchitis. Inflamm Bowel Dis. 2015;21(3):589-95. doi: 10.1097/MIB.0000000000000308. [PubMed: 25659085].
  • 17. de Serres F, Blanco I. Role of alpha-1 antitrypsin in human health and disease. J Intern Med. 2014;276(4):311-35. doi: 10.1111/joim.12239. [PubMed: 24661570].
  • 18. Manji M, Shayo G, Mamuya S, Mpembeni R, Jusabani A, Mugusi F. Lung functions among patients with pulmonary tuberculosis in Dar es Salaam - a cross-sectional study. BMC Pulm Med. 2016;16(1):58. doi: 10.1186/s12890-016-0213-5. [PubMed: 27107713].
  • 19. Pasipanodya JG, Miller TL, Vecino M, Munguia G, Garmon R, Bae S, et al. Pulmonary impairment after tuberculosis. Chest. 2007;131(6):1817-24. doi: 10.1378/chest.06-2949. [PubMed: 17400690].
  • 20. Baig IM, Saeed W, Khalil KF. Post-tuberculous chronic obstructive pulmonary disease. J Coll Physicians Surg Pak. 2010;20(8):542-4. [PubMed: 20688021].
  • 21. Marciniuk DD, Hernandez P, Balter M, Bourbeau J, Chapman KR, Ford GT, et al. Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline. Can Respir J. 2012;19(2):109-16. [PubMed: 22536580].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments